G. Deutsch

Balneotherapy is a potential risk factor for Pseudomonas aeruginosa colonization

L. M. Esper, L. A. Teixeira, G. R. Paula, 2016 .

High Efficacy and Low Toxicity of Weekly Docetaxel Given as First-Line Treatment for Metastatic Breast Cancer

M. Stauch, V. Heinemann, C. Jackisch, 2005, Oncology.

A Treatment-Naive Cellular Atlas of Pediatric Crohn's Disease Predicts Disease Severity and Therapeutic Response

A. Shalek, S. Snapper, L. Cagnin, 2021, medRxiv.

A Phase I study of letrazuril in AIDS‐related Cryptosporidiosis

J. Maclean, C. Tsoukas, G. Deutsch, 1994, AIDS.

Cost of treatment and reduction achieved by chronic ulcer in diabetic patients - a comparison between hydrogel and human recombinant Epidermal Growth Factor

Keila Mara Cassiano, G. Deutsch, S. R. Castilho, 2019 .

Molecular characterization of multidrug-resistant (MDR) Pseudomonas aeruginosa isolated in a burn center.

L. M. Esper, L. A. Teixeira, G. Deutsch, 2017, Burns : journal of the International Society for Burn Injuries.

Effectiveness of Epidermal Growth Factor Loaded Carboxymethylcellulose (EGF-CMC) Hydrogel in Biofilm Formation in Wounds of Diabetic Patients: A Randomized Clinical Trial

L. A. Teixeira, R. Thiré, G. R. Paula, 2023, Gels.

rhEGF-Loaded Hydrogel in the Treatment of Chronic Wounds in Patients with Diabetes: Clinical Cases

R. Thiré, G. Deutsch, B. I. R. D. de Oliveira, 2022, Gels.

A prospective multicenter phase II study of oral and i.v. vinorelbine plus trastuzumab as first-line therapy in HER2-overexpressing metastatic breast cancer.

H. Kölbl, V. Heinemann, C. Ziske, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Effectiveness of a synthetic human recombinant epidermal growth factor in diabetic patients wound healing: Pilot, double‐blind, randomized clinical controlled trial

G. Deutsch, B. I. R. D. de Oliveira, Bianca C. Oliveira, 2021, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.